IP Group’s board of directors on Monday unanimously rejected a sweetened 71.3 pence-per-share takeover proposal from its largest shareholder, Railpen, citing significant undervaluation of the company and its prospects.
The revised proposal valued the London-listed early-stage science investor at about £630 million ($845.27 million), excluding a contingent element that could have taken the total to about £730 million.
-
Railpen had offered IP Group shareholders 61 pence per share in cash, and a pro rata share of the company’s entire Oxford Nanopore Technologies stake valued at 10.3 pence per share.
- The proposal also included a contingent value right (CVR) of up to 11.3 pence per share linked to IP Group’s interest in Metsera — a clinical-stage biotech firm — subject to performance thresholds being met by end-2029.
- Excluding the CVR, the offer valued IP Group at 71.3 pence per share, a premium of about 10.2% to its Monday close of 64.7 pence.
- Railpen, which manages more than £34 billion in assets for railway pension schemes and holds 18.4% in IP Group, declined to comment.
- Railpen must announce a firm offer or withdraw by July 27 following a seven-day extension granted by the UK Takeover Panel.
